SCHEMBL11905305

SCHEMBL11905305

CCCCCCCCCOc1cccnc1[O]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ MAPT P10636 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ NR1I2 O75469 1/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ OPRK1 P41145 1/20 0.50
▸ HTR2B P41595 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ PDE5A O76074 3/20 0.49
▸ PDE4A P27815 3/20 0.49
▸ PDE4B Q07343 3/20 0.49
▸ PDE4C Q08493 3/20 0.49
▸ PDE4D Q08499 3/20 0.49
▸ PTPN1 P18031 1/20 0.48
▸ MCHR1 Q99705 2/20 0.47
▸ CYP1A2 P05177 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11905376 1.00 LMNA (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905595 1.00 LMNA (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905898 1.00 LMNA (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905500 1.00 LMNA (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11906167 1.00 LMNA (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905914 0.98 PDE5A (0.48) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905535 0.93 CYP2C9 (0.50) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL11905968 0.87 GRM5 (0.47) MAPTMEN1KMT2APDE5APDE4A
SCHEMBL5999885 0.82 PDE5A (0.51) LMNAMAPTMEN1NR1I2CHRM2
SCHEMBL28251707 0.81 LMNA (0.51) LMNAMAPTMEN1NR1I2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2492276-B1 METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME SUMITOMO CHEMICAL CO (JP) 2014-10-08 — — EP disclosed
US-20140183414-A1 POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-07-03 — — US disclosed
EP-2492276-A1 METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME Sumitomo Chemical Company, Limited (JP) 2012-08-29 — — EP disclosed
US-20120205585-A1 METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120205585-A1 METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME HDAC10, EMG1, PRMT1 LMNA 2365/4885MAPT 4331/4885MEN1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback